Guidelines for the prevention, diagnosis and management of NRTI-associated symptomatic hyperlactataemia and lactic acidosis

Southern African Journal of HIV Medicine

Volumn , Issue 22, 2006, Pages 8-15

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BICARBONATE; CARNITINE; CEPHALOSPORIN; DIDANOSINE; LACTIC ACID; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; METFORMIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SODIUM CARBONATE; STAVUDINE; TENOFOVIR; THIAMINE; UBIQUINONE; VITAMIN B COMPLEX; ZIDOVUDINE;

ARTICLE; BLOOD TOXICITY; CARDIOMYOPATHY; CLINICAL ASSESSMENT; CYTOPENIA; DEVELOPING COUNTRY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG FATALITY; DRUG HALF LIFE; DRUG SUBSTITUTION; FATTY LIVER; GUILLAIN BARRE SYNDROME; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTIC ACIDOSIS; LIPOATROPHY; LIVER DYSFUNCTION; METABOLIC ACIDOSIS; MITOCHONDRIAL TOXICITY; MORBIDITY; MORTALITY; MUSCLE WEAKNESS; MYOPATHY; PANCREATITIS; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PROGNOSIS; RISK ASSESSMENT; SEPSIS; SEPTICEMIA; SOUTH AFRICA; SYMPTOMATOLOGY; THREAT;

EID: 33646176143     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Pallela FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
2. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-895.
3. Simpson D, Estanislao L, Evans S, et al. HIV-associated neuromuscular weakness syndrome. AIDS 2004; 18: 1043-1412.
4. Calza L, Manfredi R, Chiodo F. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. Clin Nutr 2005; 24(1): 5-15.
5. Brinkert W, Rommes JH, Bakker J. Lactate measurements in critically ill patients with a hand-held analyser. Intensive Care Med 1999; 25: 966-969.
6. Lonergan JT, Barber RE, Mathews WC. Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis. AIDS 2003; 17: 2495-2499.
7. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. 2005. http://www.bhiva.org/guidelines/2005/HIV/HIV0Bframeset.html (last accessed 20 February 2006).
8. Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002; 31(3): 257-275.